COVID-19 Vaccine Could Soon Be a Reality

The coronavirus infection, ever since declared as a pandemic of catastrophic proportions by the World Health Organization (WHO), affecting more than 200,000 people worldwide and claiming over 8000 lives, has been sending a wave of panic amongst healthcare professionals.

Needless to say, the scientific community all over the world is working tirelessly, literally racing against time, to design an effective vaccine to combat the rapid spread of COVID-19.

One emerging life science company, Inovio Pharmaceuticals, in joint efforts with Beijing Advaccine Biotechnology Company, has successfully synthesized a potential vaccine and plan to commence with human trials in the US in April 2020, and soon after in China and South Korea.

Another promising molecule for coronavirus vaccine has been formulated by the Academy of military medical sciences in Wuhan, along with CanSino biologics, a Hong Kong-based pharmaceutical company. Clinical trials for this potential coronavirus vaccine are about to commence in China soon.

German Biotech Company, in collaboration with Fosun pharma, also plans to start clinical trials of their novel coronavirus vaccine molecule by the end of April. Scientists at Israel’s Institute for biological research, have unravelled the biological mechanism and traits of the coronavirus and are en route to formulating a promising vaccine, to combat the deadly COVID-19 pandemic as well and quite recently, their hard work was recognised in the form of an official Phase 1 clinical trial studying an investigational vaccine, at the Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, USA.This trial involved 45 healthy adults in the age group of 18 – 55 years. They will be closely monitored for a period of 6 weeks, post injecting the vaccine into their systems.



mail | whatsup 8756536895

Govind Shukla, Specializes in Pharmacology, Toxicology, Nutraceuticals & Herbal Drugs has published More than 100 research papers in National & International Journals. He is also a reviewer of International Journal of Pharmacology & pharmacotherapeutics, Chief editor of IJPNR Journal & Freelance Medical Writer for Different publication Groups including Lambert Academic Publishing Saarbrucken, Germany.

Write a comment